Citation Impact
Citing Papers
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
2000
Membrane Vesicles: an Overlooked Component of the Matrices of Biofilms
2006
BIGSdb: Scalable analysis of bacterial genome variation at the population level
2010 Standout
A proteoliposome formulation derived from Bordetella pertussis induces protection in two murine challenge models
2013
Needle-free influenza vaccination
2010
Serogroup B meningococcal vaccines—an unfinished story
2010
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Immune modulation by bacterial outer membrane vesicles
2015
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
2020 Standout
Immunization without needles
2005
Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication?
2018 StandoutNobel
Molecular typing of meningococci: recommendations for target choice and nomenclature
2006
The Diagnosis and Management of Acute Otitis Media
2013 Standout
Improved methods for producing outer membrane vesicles in Gram-negative bacteria
2004
A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Protection against Lethal Sepsis
2014
From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak
2011
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Biofilms: an emergent form of bacterial life
2016 Standout
Immunology of bacterial polysaccharide antigens
2003
The biofilm matrix
2010 Standout
Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale
2013
Interactions between Coagulation and Inflammation
2003
Selective Sorting of Cargo Proteins into Bacterial Membrane Vesicles
2010
Meningococcal Disease
2001
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
2015 Standout
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Microneedles for drug and vaccine delivery
2012 Standout
The respiratory microbiota: associations with influenza symptomatology and viral shedding
2019
Microbiota Modulation of the Gut-Lung Axis in COVID-19
2021 Standout
Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine
2010
A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression
2011
Physicochemical and Immunological Characterization of N,N,N-Trimethyl Chitosan-Coated Whole Inactivated Influenza Virus Vaccine for Intranasal Administration
2009
Extracellular vesicles: biology and emerging therapeutic opportunities
2013 Standout
Bacterial Outer Membrane Vesicles and Vaccine Applications
2014
Characterization of a transcriptional TPP riboswitch in the human pathogen Neisseria meningitidis
2020 StandoutNobel
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Proteomic Characterization and Functional Analysis of Outer Membrane Vesicles of Francisella novicida Suggests Possible Role in Virulence and Use as a Vaccine
2010
Chitosan—A versatile semi-synthetic polymer in biomedical applications
2011 Standout
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
2000
Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles
2010
A Two-Component Regulatory System Impacts Extracellular Membrane-Derived Vesicle Production in Group A Streptococcus
2016 StandoutNobel
Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children
2008
Nanoemulsions: formation, properties and applications
2016 Standout
Protective Immunity to Bordetella pertussis Requires Both B Cells and Cd4+ T Cells for Key Functions Other than Specific Antibody Production
2000
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
2015 Standout
Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane Vesicles
2010 Standout
Lipopolysaccharide Endotoxins
2002 Standout
Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspecies
2005 Standout
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
Correlates of Protection Induced by Vaccination
2010 Standout
Mycobacterial Membrane Vesicles Administered Systemically in Mice Induce a Protective Immune Response to Surface Compartments of Mycobacterium tuberculosis
2014
Works of Johan Holst being referenced
Strategies for Development of Universal Vaccines Against Meningococcal Serogroup B Disease
2007
Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys
2000
Can nonliving nasal vaccines be made to work?
2002
Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine
2000
A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin
1997
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
2013
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
2009
A Non-Living Nasal Influenza Vaccine Can Induce Major Humoral and Cellular Immune Responses in Humans without the Need for Adjuvants
2005
Outer Membrane Protein Vesicle Vaccines for Meningococcal Disease
2003
OUTER MEMBRANE VESICLES FROM NEISSERIA MENINGITIDIS: EFFECTS ON CYTOKINE PRODUCTION IN HUMAN WHOLE BLOOD
2001
Outer Membrane Vesicles from Neisseria meningitidis: Effects on Tissue Factor and Plasminogen Activator Inhibitor-2 Production in Human Monocytes
2001
Intranasal Administration of a Meningococcal Outer Membrane Vesicle Vaccine Induces Persistent Local Mucosal Antibodies and Serum Antibodies with Strong Bactericidal Activity in Humans
1998
Meningococcal Outer Membrane Vesicle Vaccine Given Intranasally Can Induce Immunological Memory and Booster Responses without Evidence of Tolerance
2001